Immunocore Holdings (IMCR) EBIAT: 2021-2025
Historic EBIAT for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$177,000.
- Immunocore Holdings' EBIAT fell 102.03% to -$177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 37.88%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' EBIAT is -$177,000, which was up 98.28% from -$10.3 million recorded in Q2 2025.
- Immunocore Holdings' EBIAT's 5-year high stood at $8.7 million during Q3 2024, with a 5-year trough of -$53.2 million in Q4 2021.
- For the 3-year period, Immunocore Holdings' EBIAT averaged around -$10.2 million, with its median value being -$11.6 million (2024).
- As far as peak fluctuations go, Immunocore Holdings' EBIAT soared by 864.24% in 2024, and later plummeted by 102.03% in 2025.
- Immunocore Holdings' EBIAT (Quarterly) stood at -$53.2 million in 2021, then reached -$19.7 million in 2023, then fell by 20.48% to -$23.8 million in 2024, then tumbled by 102.03% to -$177,000 in 2025.
- Its last three reported values are -$177,000 in Q3 2025, -$10.3 million for Q2 2025, and $5.0 million during Q1 2025.